NEW YORK, May 17 (GenomeWeb News) - As part of its ongoing transition from a genomics company to a pharmaceutical firm, Incyte hopes to auction off many of its genomic research and laboratory equipment, GenomeWeb News has learned.
DoveBid, a capital asset auction and valuation company, has reported on its website that it will hold a webcast auction of various Incyte assets deemed "surplus to [the company's] continuing operations."
Among the items up for sale are a Cytomation S-1312 MoFlo high performance cell sorter, centrifuges, ultracentrifuges, and automatic pipetors, said DoveBid.
The auction will be held on June 15 at 9 a.m. Pacific Daylight Time. Details about the event can be found at here.